Managers' transactions announcement according to article 19 MAR

Paiania, 12 May 2023 – Lavipharm S.A., according to the provisions of article 19 of the European Regulation No 596/2014 and following relevant notification, announces that Mr. Thomas Tseronis, Head of Sales Rx, sold 35.434 Lavipharm common shares, amounting in total to Euro 15.732,7.

###